Top Banner
Chapter 25 Hypersensitivity (Type III) Trai-Ming Yeh, Ph.D. Department of Medical Laboratory Science and Biotechnology College of Medicine National Cheng Kung University
40

Chapter 25 Hypersensitivity (Type III)

Jan 03, 2016

Download

Documents

Holly Gilbert

Chapter 25 Hypersensitivity (Type III). Trai-Ming Yeh, Ph.D. Department of Medical Laboratory Science and Biotechnology College of Medicine National Cheng Kung University. Diseases caused by immune complexes can be divided into three groups. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Chapter 25  Hypersensitivity (Type III)

Chapter 25 Hypersensitivity (Type III)

Trai-Ming Yeh, Ph.D.

Department of Medical Laboratory Science and Biotechnology

College of Medicine

National Cheng Kung University

Page 2: Chapter 25  Hypersensitivity (Type III)

Diseases caused by immune complexes can be divided into three groups.

Page 3: Chapter 25  Hypersensitivity (Type III)

Persistent infection with a weak antibody response can lead to immune complex disease

Renal arteryFITC (green)anti-HBsAgRhodamine (red)anti-IgM

Page 4: Chapter 25  Hypersensitivity (Type III)

Immune complex disease is a frequent complication of autoimmune disease

Page 5: Chapter 25  Hypersensitivity (Type III)

Immune complex following inhalation of antigen: extrinsic allergic alveolitis

Precipitin antibody (P) present in the serum of a patient with pigeon fancier's lung (3) is directed against the fungal antigen Micropolyspora faeni. Normal serum (N) lacks antibodies to this fungus.

Page 6: Chapter 25  Hypersensitivity (Type III)

Immune complexes can trigger a variety of inflammatory processes

Page 7: Chapter 25  Hypersensitivity (Type III)

Type II and type III hypersensitivity cause damage by similar mechanismsComplement is an important mediator of type III hypersensitivity

Page 8: Chapter 25  Hypersensitivity (Type III)

Autoimmunity causes immune complex disease in the NZB/NZW mouse

Page 9: Chapter 25  Hypersensitivity (Type III)

Experimental models demonstrate the main immune complex diseases

Page 10: Chapter 25  Hypersensitivity (Type III)

Injection of antigen into the skin of presensitized animals produces the Arthus reaction

Page 11: Chapter 25  Hypersensitivity (Type III)

Type I 15 min

Type III (Arthus reaction)5-12 h

Type IV214-48 h

Page 12: Chapter 25  Hypersensitivity (Type III)

CR1 on RBC readily binds immune complexes

Page 13: Chapter 25  Hypersensitivity (Type III)

Immunocomplexes are transported to the liver and spleen, where they are removed by fixed tissue

macrophages

I-125 lable BSA /anti-BSA removed in liver

Page 14: Chapter 25  Hypersensitivity (Type III)

Complement solubilization of immune complexes in vitro

Complement can rapidly resolubilize precipitated complexes through the alternative pathway.

Page 15: Chapter 25  Hypersensitivity (Type III)

1. Non-erythrocyte-bound complexes are taken up rapidly by the liver (but not the spleen) and are then released to be deposited in tissues such as skin, kidney, and muscle, where they can set up inflammatory reactions.

2. Complement deficiency impairs clearance of complexes.

Page 16: Chapter 25  Hypersensitivity (Type III)

The size of immune complexes affects their deposition

1. Larger immune complexes are rapidly removed

2. Phagocyte defects allow complexes to persist

3. Carbohydrate on antibodies affects complex clearance

Page 17: Chapter 25  Hypersensitivity (Type III)

The class of immunoglobulin in an immune complex can also influence its deposition: IgM to IgG2a in SLE mice

Ig classes affect the rate of clearance

Page 18: Chapter 25  Hypersensitivity (Type III)

Immune complex deposition in the tissues results in tissue damage-But what cause it to

deposit?• The most important trigger for immune complex

deposition is probably an increase in vascular permeability-vasoactive amine antagonists, such as chlorpheniramine and methysergide prevent tissue damage (Fig. 25.18).

• Immune complex deposition is most likely where there is high blood pressure and turbulence (Fig. 25.19)-kidney

Page 19: Chapter 25  Hypersensitivity (Type III)

Summary of Chapter 25 Hypersensitivity (III) • Diseases caused by immune complexes can be

divided into three groups. • Immune complexes can trigger a variety of

inflammatory processes. • Experimental models demonstrate the main immune

complex diseases. • Immune complexes are normally removed by the

mononuclear phagocyte system. • The size of immune complexes affects their

deposition. • Immune complex deposition in the tissues results in

tissue damage.• Deposited immune complexes can be visualized

using immunofluorescence.

Page 20: Chapter 25  Hypersensitivity (Type III)

Chapter 26 Hypersensitivity (Type IV)-

antigen-specific CD4 T cells

Trai-Ming Yeh, Ph.D.

Department of Medical Laboratory Science and Biotechnology

College of Medicine

National Cheng Kung University

Page 21: Chapter 25  Hypersensitivity (Type III)

THERE ARE THREE VARIANTS OF TYPE IV HYPERSENSITIVITY REACTION

Page 22: Chapter 25  Hypersensitivity (Type III)

Contact hypersensitivity occurs at the point of contact with allergen (haptan)

such as nickel, chromate…

Page 23: Chapter 25  Hypersensitivity (Type III)

1. Contact hypersensitivity is primarily an epidermal reaction, and the dendritic Langerhans' cell, located in the suprabasal epidermis, is the principal antigen-presenting cell (APC) involved

2. Birbeck granules, which are organelles derived from cell membrane and are characteristic of Langerhans' cells

3. Keratinocytes produce a range of cytokines important to the contact hypersensitivity response

Page 24: Chapter 25  Hypersensitivity (Type III)

1. A contact hypersensitivity reaction has two stages-sensitization and elicitation

2. Sensitization (takes 10-14 days in humans) stimulates a population of memory T cells

3. Elicitation involves recruitment of CD4+ lymphocytes and monocytes

Page 25: Chapter 25  Hypersensitivity (Type III)
Page 26: Chapter 25  Hypersensitivity (Type III)

Cytokines and prostaglandins are central to the complex interactions between Langerhans' cells, CD4+ T cells, keratinocytes, macrophages, and endothelial cells in contact hypersensitivity

Page 27: Chapter 25  Hypersensitivity (Type III)

TUBERCULIN-TYPE HYPERSENSITIVITY

Page 28: Chapter 25  Hypersensitivity (Type III)

1. The tuberculin skin test reaction is an example of the recall response to soluble antigen previously encountered during infection which involves monocytes and lymphocytes

2. The tuberculin lesion normally resolves within 5-7 days, but if there is persistence of antigen in the tissues it may develop into a granulomatous reaction.

Page 29: Chapter 25  Hypersensitivity (Type III)

GRANULOMATOUS HYPERSENSITIVITY

• intracellular microorganisms such as M. tuberculosis and M. leprae, which are able to resist macrophage killing leads to chronic stimulation of T cells and the release of cytokines.

• The process results in the formation of epithelioid cell granulomas with a central collection of epithelioid cells and macrophages surrounded by lymphocytes

Page 30: Chapter 25  Hypersensitivity (Type III)

Macrophages, lymphocytes, epithelioid cell, and giant cells in granulomas

• Granulomas occur with chronic infections associated with predominantly TH1-like T cell responses, such as tuberculosis, leprosy, and leishmaniasis, and with TH2-like T cells, as in schistosomiasis.

• Epithelioid cells large and flattened with increased endoplasmic reticulum (Fig. 26.11) are derived from activated macrophage under chronic stimulation

• Giant cells are formed when epithelioid cells fuse to form multinucleate giant cells (Fig. 26.12)

Page 31: Chapter 25  Hypersensitivity (Type III)
Page 32: Chapter 25  Hypersensitivity (Type III)

Tuberculin-like DTH reactions are used practically in two ways: confirms past or latent infection with M. tuberculosis or measure of cell-mediated immunity

Page 33: Chapter 25  Hypersensitivity (Type III)

IFNγ is required for granuloma formation in humans

Page 34: Chapter 25  Hypersensitivity (Type III)

TNF and lymphotoxin-α are also essential for granuloma formation during mycobacterial infections

Page 35: Chapter 25  Hypersensitivity (Type III)

TNF is essential for the development of epithelioid cell granulomas

Page 36: Chapter 25  Hypersensitivity (Type III)

Many chronic diseases manifest type IV granulomatous hypersensitivity

borderline leprosy has characteristics of both tuberculoid and lepromatous (no protection) leprosy

Page 37: Chapter 25  Hypersensitivity (Type III)

tuberculoid-type reaction, lymphocyte proliferation or the release of IFNγ following stimulation with M. leprae antigens

Page 38: Chapter 25  Hypersensitivity (Type III)

Tuberculosis is caused by M. tuberculosis

• The reactions are frequently accompanied by extensive fibrosis and the lesions may be seen in the chest radiographs of affected patients

• The histological appearance of the lesion is typical of a granulomatous reaction, with central caseous (cheesy) necrosis

Page 39: Chapter 25  Hypersensitivity (Type III)

Summary of Chapter 26 Hypersensitivity (Type IV)

• DTH reflects the presence of antigen-specific CD4 T cells.

• Contact hypersensitivity occurs at the point of contact with an allergen.

• Tuberculin-type hypersensitivity is induced by soluble antigens from a variety of organisms.

• Granulomatous hypersensitivity is clinically the most important form of type IV hypersensitivity.

• Many chronic diseases manifest type IV granulomatous hypersensitivity.

Page 40: Chapter 25  Hypersensitivity (Type III)

Important points needed to understand after class

• Understand the role of immune complex.• Understand the role of immune complex in tissue

damage. • Understand the role of type IV hypersensitivity on

diagnosis and treatment of various diseases.